Ajanta Pharma

Market Cap (₹ Cr.)

₹39,351

52 Week High

3,485.00

Book Value

₹283

52 Week Low

1,650.05

PE Ratio

46.09

PB Ratio

11.03

PE for Sector

57.62

PB for Sector

19.92

ROE

22.88 %

ROCE

58.78 %

Dividend Yield

1.62 %

EPS

₹67.81

Industry

Pharmaceuticals

Sector

Pharmaceuticals - Indian - Formulations

Investment Returns

In Long Term

In Short Term

1 Year

0.00%

2 Years

0.00%

3 Years

0.00%

4 Years

0.00%

5 Years

0.00%

Growth Rate

Revenue Growth

11.77 %

Net Income Growth

38.81 %

Cash Flow Change

-0.89 %

ROE

31.83 %

ROCE

44.38 %

EBITDA Margin (Avg.)

27.48 %

Financial Results

Quarterly Financials	Mar 2015	Jun 2015	Sept 2015	Dec 2015	Mar 2016	Jun 2016	Sept 2016	Dec 2016	Mar 2017	Jun 2017	Sept 2017	Dec 2017	Mar 2018	Jun 2018	Sept 2018	Dec 2018	Mar 2019	Jun 2019	Sept 2019	Dec 2019	Mar 2020	Jun 2020	Sept 2020	Dec 2020	Mar 2021	Jun 2021	Sept 2021	Dec 2021	Mar 2022	Jun 2022	Sept 2022	Dec 2022	Mar 2023	Jun 2023	Sept 2023	Dec 2023	Mar 2024	Jun 2024
Revenue	372	355	417	429	450	426	484	560	434	403	477	565	469	511	482	465	417	585	599	582	615	574	763	736	749	774	876	836	794	886	916	905	886	1,046	997	1,099	960	1,106
Expenses	235	231	266	275	276	275	309	333	285	288	312	347	347	301	323	321	346	406	412	393	457	387	426	488	501	510	591	571	578	664	677	715	704	738	672	758	699	761
EBITDA	137	125	151	154	174	151	175	226	149	115	165	218	121	210	159	144	70	179	187	189	157	187	337	248	248	264	285	266	216	222	239	190	181	308	326	341	261	344
Operating Profit %	35 %	31 %	32 %	34 %	31 %	34 %	35 %	34 %	32 %	28 %	34 %	31 %	25 %	32 %	31 %	29 %	16 %	26 %	26 %	26 %	18 %	31 %	37 %	33 %	33 %	31 %	28 %	29 %	24 %	22 %	19 %	18 %	17 %	27 %	29 %	30 %	25 %	29 %
Depreciation	13	10	10	11	12	12	13	15	19	13	14	14	16	17	17	18	18	22	22	23	25	27	27	28	29	30	30	31	30	31	32	32	32	32	33	33	33	33
Interest	1	1	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	1	4	1	3	1	1	2	2	1	0	1	7	1	1	3	1	1	2	2	1	1
Profit Before Tax	123	114	140	142	162	138	162	211	130	102	151	204	105	193	142	126	52	156	161	166	130	158	309	218	217	233	255	234	178	190	207	155	148	275	291	305	226	311
Tax	39	32	45	38	17	36	43	39	19	22	32	40	21	42	31	27	8	29	35	61	42	38	74	36	69	36	55	33	47	42	46	18	39	61	75	82	60	71
Net Profit	84	82	95	104	138	100	121	171	108	77	108	165	79	151	104	95	41	124	121	108	89	116	225	180	155	193	197	195	135	150	167	124	117	212	212	220	163	236
EPS in ₹	9.59	9.31	10.79	11.81	15.68	11.35	13.75	19.42	12.27	8.72	12.24	18.70	8.92	17.14	11.83	10.85	4.70	14.17	13.83	12.41	10.14	13.26	25.81	20.80	17.89	22.36	15.17	22.50	15.79	11.74	13.05	9.67	9.15	16.84	16.87	17.48	12.92	18.77

Show % Change

Above figures are in Rs. Crores

Balance Sheet

Balance Sheet	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total Assets	1,086	1,414	1,749	2,292	2,522	3,049	3,532	3,780	4,305	4,217
Fixed Assets	271	433	573	1,037	1,162	1,449	1,519	1,492	1,484	1,465
Current Assets	573	698	775	1,095	1,048	1,415	1,836	2,057	2,551	2,442
Capital Work in Progress	170	240	339	61	261	131	108	153	209	256
Investments	19	94	199	201	83	86	157	165	553	367
Other Assets	625	647	638	993	1,015	1,383	1,748	1,970	2,058	2,129
Total Liabilities	300	282	245	360	379	588	647	611	1,058	804
Current Liabilities	245	242	212	300	307	475	516	470	908	630
Non Current Liabilities	55	40	32	60	73	113	131	142	151	174
Total Equity	786	1,132	1,504	1,932	2,142	2,461	2,885	3,169	3,246	3,414
Reserve & Surplus	769	1,114	1,486	1,914	2,125	2,444	2,868	3,152	3,221	3,388
Share Capital	18	18	18	18	18	18	17	17	25	25

Show % Change

Above figures are in Rs. Crores

Cash Flow

Cash Flow	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Net Cash Flow	16	9	-1	18	-6	51	35	19	130	-207
Investing Activities	-146	-139	-340	-201	-137	-116	-163	-66	-501	105
Operating Activities	263	277	537	219	312	301	467	542	736	735
Financing Activities	-101	-128	-198	-1	-181	-134	-269	-457	-105	-1,048

Show % Change

Above figures are in Rs. Crores

Share Holding

% Holding	Mar 2021	Jun 2021	Sept 2021	Dec 2021	Mar 2022	Jun 2022	Sept 2022	Dec 2022	Mar 2023	Apr 2023	Jun 2023	Sept 2023	Dec 2023	Mar 2024	Jun 2024
Promoter	70.34 %	70.34 %	70.34 %	70.34 %	70.48 %	70.48 %	70.48 %	66.11 %	66.11 %	66.21 %	66.21 %	66.21 %	66.21 %	66.21 %	66.27 %
FIIs	8.37 %	8.94 %	8.72 %	8.95 %	8.64 %	8.30 %	8.23 %	10.07 %	10.00 %	10.03 %	10.19 %	9.99 %	9.11 %	8.54 %	8.36 %
DIIs	11.86 %	11.82 %	12.07 %	12.14 %	12.29 %	12.46 %	13.14 %	15.82 %	15.98 %	16.02 %	15.81 %	15.59 %	16.68 %	17.49 %	17.41 %
Government	0.76 %	0.43 %	0.43 %	0.45 %	0.45 %	0.45 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.01 %
Public / Retail	8.67 %	8.47 %	8.43 %	8.12 %	8.14 %	8.31 %	8.15 %	8.00 %	7.91 %	7.74 %	7.78 %	8.20 %	8.01 %	7.76 %	7.94 %

Show % Change

Peer Comparison Compare Peers on Screener

Competitors	LTP	Market Cap (₹ Cr.)	P/E Ratio	Revenue (₹ Cr.)	YoY Revenue Growth %	Net Profit (₹ Cr.)	YoY Profit Growth %	RSI
Torrent Pharmaceuticals	3,359.60	1,16,815.97	69.82	10,785.75	11.59	1,656	20.90	47.50
Ajanta Pharma	3,121.15	39,351.06	46.09	4,293.31	11.77	816	18.09	49.72
Gland Pharma	1,841.50	30,430.47	42.14	5,834.96	50.97	772	-25.94	37.24
Eris Lifesciences	1,397.05	18,928.93	49.77	2,032.96	19.85	397	-4.52	62.53
Caplin Point Laboratories	1,965.50	15,241.11	31.91	1,761.04	15.65	461	19.85	57.70
Marksans Pharma	281.22	13,424.98	40.20	2,227.83	16.55	315	26.45	67.40
Shilpa Medicare	901.90	8,720.99	212.33	1,159.77	8.64	32	1,091.53	73.96
Jeena Sikho Lifecare	1,406.80	3,353.63	100.45	207.35	40.06	34	-	55.67
Amrutanjan Health Care	804.90	2,253.29	52.91	192.42	12.50	21	-34.09	56.41
Syncom Formulations	23.18	2,241.90	79.50	238.85	3.11	20	73.41	56.92